The goal of this patient registry is to describe risk factors for bad prognosis of melanoma in Spain. The main questions it aims to answer are: * To describe socioeconomical individual risk factors associated with melanoma prognosis, such as gender, residence area or socioeconomic level. * To describe potentially modifiable characteristics of health care associated with prognosis, such as waiting times, type of centre that makes the diagnosis or use of teledermatology Participants data will be gathered for analysis, without any change in the way that they are being treated.
Study Type
OBSERVATIONAL
Enrollment
7,000
Hospital Universitari Germans Trias i Pujol
Badalona, Barcelona, Spain
RECRUITINGComplexo Hospitalario Universitario de A Coruña
A Coruña, Spain
NOT_YET_RECRUITINGHospital Clinic
Barcelona, Spain
RECRUITINGHospital San Juan de Dios
Córdoba, Spain
RECRUITINGHospital Universitario de Gran Canaria Dr Negrín
Las Palmas, Spain
RECRUITINGComplejo Asistencial Universitario de León
León, Spain
RECRUITINGClínica Dermatológica Internacional
Madrid, Spain
NOT_YET_RECRUITINGClínica Universitaria de Navarra ( sede de Madrid)
Madrid, Spain
RECRUITINGHospital Clínico San Carlos
Madrid, Spain
RECRUITINGHospital La Paz
Madrid, Spain
RECRUITING...and 11 more locations
AJCC (American Joint Committee on Cancer) TNM stage (Tumor, node, metastasis)
Staging based on tumor thickness and ulceration, spread to lymph nodes and spread to distant sites.
Time frame: 1 day At diagnosis
Breslow thickness
Breslow thickness is the measurement of the depth of the melanoma from the surface of your skin down through to the deepest point of the tumour.
Time frame: 1 day At diagnosis
Time to progression
Time frame: through study completion, an average of 3 years
Survival
Time frame: through study completion, an average of 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.